Delska
Delska is a data center and network operator that provides tailor-made IT and network services for businesses. With 5 data centers (one under construction, launching in 2025) in Latvia and Lithuania, and points of presence in Germany, Netherlands, and Sweden, we offer a comprehensive regional data center and network ecosystem. By 2030, we aim to achieve net-zero CO2 emissions, setting standard for sustainable IT infrastructure in the Baltic region.
In addition to cloud computing, colocation, data security, network, and other services, we have launched the self-service cloud platform myDelska for swift virtual machine deployment, IT resources management, and soon-to-come bare metal services.
Key features:
• Unlimited traffic and predictable monthly costs
• API integration
• Flexible firewall configurations
• Backup solutions
• Real-time network topology
• Latency measurement map
• Alpine Linux, Ubuntu, Debian, Windows OS, openSUSE and other operating systems
Since June 2024, Delska has merged 2 companies—DEAC European Data Center and Data Logistics Center (DLC). Both operate under their respective legal entities, which are owned by Quaero European Infrastructure Fund II.
Learn more
CLEAR
The CLEAR™ Cryptosystem is a FIPS-140-3 validated encryption SDK designed to secure files, streaming media, databases, and network communications with cutting-edge, programmable encryption technology. Fully compatible with all modern computing platforms, CLEAR™ provides a simple, turnkey solution for integrating advanced encryption into existing security systems. With Post-Quantum Cryptography (PQC) capabilities, it delivers future-proof protection against emerging cybersecurity threats, ensuring your data is secured with the strongest available encryption methods.
Key Features:
• PQC Encryption Strength ( 512bit - 10,240bit)
• Ultra Low-Latency Streaming (< 11µs / Packet)
• Hyperkey™ Technology with embedded ACL
• Multi-Factor / Bio-Metric Symmetric Keys
• Plug-N-Play Entropy - CSRNG, QRNG, HRNG
Benefits:
• Pass cybersecurity audits with best-in-class tools
• Share data securely via Sharepoint, Dropbox, etc.
• Protect legacy gear and outdated network equipment
• Extend protection to files in 3rd party portals
• Future lasting power - long-term data archival
Learn more
SYNTHIA Retrosynthesis Software
SYNTHIA™ Retrosynthesis software, developed by computer scientists and coded by chemists, allows scientists to quickly and easily navigate novel and innovative pathways for novel and previously published target molecules.
You can quickly and efficiently scan hundreds pathways to identify the best options for your needs.
Discover the most cost-effective route to your target molecule with the latest visualization and filtering features.
You can easily customize the search parameters to eliminate or highlight reactions, reagents, or classes of molecules.
Explore innovative and unique syntheses to build your desired molecule.
Easy to generate a list for starting materials that are commercially available for your synthesis.
ISO/IEC 27001 Information Security Certification will guarantee the confidentiality, integrity and protection of your data.
Learn more
BIOVIA Discovery Studio
The biopharmaceutical sector today is characterized by its intricacy, driven by increasing demands for enhanced specificity and safety, the emergence of new treatment classes, and the complexity of disease mechanisms. To navigate this intricate landscape, a profound comprehension of therapeutic dynamics is essential. Advanced modeling and simulation techniques offer a distinctive approach to investigate biological and physicochemical phenomena at the atomic scale. This methodology not only informs physical experimentation but also expedites the drug discovery and development phases. BIOVIA Discovery Studio integrates more than three decades of peer-reviewed research with cutting-edge in silico methodologies, including molecular mechanics, free energy assessments, and biotherapeutics developability, all within a unified framework. By equipping researchers with a comprehensive suite of tools, it facilitates a deeper examination of protein chemistry, thereby accelerating the discovery of both small and large molecule therapeutics, from Target Identification all the way through to Lead Optimization. Ultimately, this synergy of research and technology underscores the vital role of innovative tools in transforming biopharmaceutical advancements.
Learn more
